# Sinclair Dunlop

> Sinclair Dunlop is a Series A investor at Masa Life Science Fund backing Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Masa Life Science Fund](https://shizune.co/investors/profile/masa-life-science-fund)
- Location: Edinburgh, United Kingdom
- Total investments: 2
- Last investment: Jun 2009
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/sinclair-dunlop-6206083

Sinclair Dunlop is a Series A investor at Masa Life Science Fund in Edinburgh focused on Health Care and Therapeutics. Mr. Dunlop has twenty years of experience successfully partnering new technologies with and delivering competitive returns to international investors. Prior to co-founding Rock Spring Ventures, Mr. Dunlop successfully raised MASA Life Science Ventures, LP (“MLSV” – www.mlsvfund.com). MLSV’s investors include several leading institutions andcorporations in Japan and Korea, including a ‘top-ten’ Japanese Pharmaceutical company, the largest distributor of cardiac-health medical devices in Japan, a global financial institution and one of Japan’s leading publicly-traded Biotechnology companies. Mr. Dunlop’s international network of blue-chip co-investors, his experienced management team and a Scientific Advisory Board of renowned experts successfully built and managed a portfolio of leading life science companies. As Managing Partner of MLSV, he currently serves on the Board of Directors of Maxcyte Inc. and Apellis Pharmaceuticals Inc. He holds an M.B.A. from Columbia Business School, an M.A. (Honours) in Political Economy from Glasgow University, and a M.A. in International Relations from Syracuse University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MediQuest Therapeutics | MediQuest is a specialty pharmaceutical / biotechnology company specializing in first in class and best in class topical drug delivery systems. Primary focus is on the discovery, development, and commercialization of products for the topical treatment of inflammatory and infectious diseases. | $23M | Series B | Jun 16, 2009 |  |
| MediQuest Therapeutics | MediQuest is a specialty pharmaceutical / biotechnology company specializing in first in class and best in class topical drug delivery systems. Primary focus is on the discovery, development, and commercialization of products for the topical treatment of inflammatory and infectious diseases. | $16M | Series A | Jun 15, 2006 |  |

2 of 2 investments shown.

## Co-investors
- [Novo Ventures](https://shizune.co/investors/profile/novo-ventures) — VC Fund, 1 deal together

## About Masa Life Science Fund

VC Fund · Washington, United States

Masa Life Science Fund is a venture capital fund focused on investments in private, high-growth biotechnology, and life sciences companies.

1 contacts available at Masa Life Science Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Sinclair Dunlop | Founder and Managing Partner | https://shizune.co/investors/profile/sinclair-dunlop |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Sinclair Dunlop invest in?

Sinclair Dunlop invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sinclair Dunlop last invest?

The most recent investment recorded for Sinclair Dunlop closed in Jun 2009. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co